Rethinking Ownership, Stablecoins, and Tokenization from First Principles

docturnal

company

About

Docturnal is an online platform that enables individuals to find information and diagnostic services related to diabetes, cancer, and more.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Diabetes,Health Care,Health Diagnostics
Founded date
Apr 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Docturnal offers custom content for diabetes, heart, cancer, Autism, and Arthritis for users who have a condition or their concerned ones.

The company is a point of care screening and diagnostics provider of non-invasive and proactive detection of diseases. Docturnal’s product portfolio also includes solutions for CoPD and Asthma with a pipeline of lung based ailments that can be identified by an aural component. Docturnal products are designed to make detection of diseases easy and hassle-free. Essentially it means being accessible and affordable to the last mile.

Docturnal was established in April 2016.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
docturnal has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 3, 2017 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 3, 2017 Seed 1 AIRmaker Detail

Investors

Number of Lead Investors
Number of Investors
1
1
docturnal is funded by 1 investors. AIRmaker are the most recent investors.
Investor Name Lead Investor Funding Round
AIRmaker Yes Seed